Neumora Therapeutics, Inc. Common Stock

NMRA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$142,148$374,038$240,943$409,247
Short-Term Investments$165,430$79,944$130,941$0
Receivables$0$939$919$200
Inventory$0$0$0$0
Other Curr. Assets$6,477$0$50$125
Total Curr. Assets$314,055$478,279$387,955$415,603
Property Plant & Equip (Net)$2,917$6,858$10,642$4,041
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$9,845$23,511$0
Tax Assets$0$0$0$0
Other NC Assets$0$1,213$4,126$9,653
Total NC Assets$2,917$17,916$38,279$13,694
Other Assets$0$0$0$0
Total Assets$316,972$496,195$426,234$429,297
Liabilities
Payables$3,307$337$7,147$1,639
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$10,108$10,150$10,044$8,133
Total Curr. Liab.$29,886$25,111$23,697$23,278
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$22$155$844,315$730,244
Total NC Liab.$22$2,008$849,387$731,240
Other Liabilities$0$0$0$0
Cap. Leases$1,853$5,231$8,442$2,052
Total Liabilities$29,908$27,119$873,084$754,518
Equity
Pref Stock$0$0$0$0
Common Stock$16$16$3$3
Retained Earnings-$947,221-$703,434-$467,509-$336,605
AOCI$62-$76-$774$0
Other Equity$0$0$0$0
Total Equity$287,064$469,076-$446,850-$325,221
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$316,972$496,195$426,234$429,297
Net Debt-$142,148-$374,038-$240,943-$409,247